MARK SOLUTIONS INC
10-Q, 1997-11-13
PREFABRICATED METAL BUILDINGS & COMPONENTS
Previous: GABELLI FUNDS INC ET AL, SC 13D/A, 1997-11-13
Next: NEWMIL BANCORP INC, 10-Q, 1997-11-13





                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                               ------------------

                                   FORM 10-Q

                               ------------------

(Mark One)

   X      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
  ---      SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:         September 30, 1997

           TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
            SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to

                               ------------------
                         Commission File Number 0-17118

                              MARK SOLUTIONS, INC.
           Incorporated pursuant to the laws of the State of Delaware

                               ------------------

       Internal Revenue Service -- Employer Identification No. 11-2864481

   Parkway Technical Center, 1515 Broad Street, Bloomfield, New Jersey, 07003
                                 (973) 893-0500

                               ------------------

Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report

Indicate by check whether  registrant  (1) has filed all reports  required to be
filed by Section 13 or 15(d) of the  Securities  Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that  registrant was required to
file such reports), and (2) has been subject to such filing requirements for the
past 90 days. Yes [X] No [ ]

The total number of shares of the  registrant's  Common Stock,  $ .01 par value,
16,972,212 shares outstanding as of November 12, 1997.



                                       1
<PAGE>

                              MARK SOLUTIONS, INC.
                                    Form 10-Q
                                       for
                        Quarter Ended September 30, 1997

                                      Index

                                                                           Page

Part I -- FINANCIAL INFORMATION
     Item 1. Financial Statements
                Consolidated Balance Sheets as of
                  September 30, 1997 and June 30, 1997 ..................    3
                Consolidated Statements of Operations for the
                  Three Months Ended September 30, 1997 and
                  September 30, 1996 ....................................    5
                Consolidated Statements of Cash Flows
                  for the Three Months Ended September 30,
                  1997 and September 30, 1996 ...........................    6
                Notes to Consolidated Financial Statements...............    7
     Item 2. Management's Discussion and Analysis of
              Financial Condition and Results of
                Operations ............................... ..............    9


Part II -- OTHER INFORMATION

     Item 6. Exhibits and Reports on Form 8-K ............................   12
     Signatures ..........................................................   12




                                       2
<PAGE>



                           Consolidated Balance Sheet

                                     Assets

                                                September 30       June 30
                                                    1997             1997    
                                                    ----             ----    

Current Assets:
Cash and cash equivalents .....................   $  767,910   $  422,457
Restricted Cash ...............................      137,500        - - -
Accounts receivable, less
 allowance of $5,500 at
 September 30 and June 30,1997 ................    1,805,788    3,178,928
Inventories ...................................      701,358      336,287
Other current assets ..........................      173,741      230,748
                                                  ----------   ----------

   Total Current Assets .......................   $3,586,297   $4,168,420
                                                  ----------   ----------

Property and Equipment:

Machinery and equipment ....  .................    1,538,775    1,488,255
Demonstration equipment .......................      395,419      395,419
Office furniture and equipment ................      347,929      401,731
Leasehold improvements ........................       55,662       41,568
Vehicles ......................................       62,283       62,283
Property held under capital lease..............       60,001       47,129
                                                  ----------   ----------
     Total ....................................    2,460,069    2,436,385
Less: Accumulated depreciation and
      amortization ............................    2,132,303    2,089,126
                                                  ----------   ----------
  Net Property and Equipment ..................      327,766      347,259
                                                   ----------   ----------
Other Assets:

Cost in excess of net assets of
 business acquired less accumulated
 amortization of $279,918 and $227,433
 at September 30,1997 and June 30, 1997,
 respectively ..................................      769,773      822,258
Other assets ...................................      109,507       94,340
                                                   ----------   ----------
  Total Other Assets ...........................      879,280      916,598
                                                   ----------   ----------
Total Assets ...................................   $4,793,343   $5,432,277
                                                   ===========  ===========



                                       3
<PAGE>


                           Consolidated Balance Sheet

               Liabilities and Stockholders' Equity (Impairment)

                                            September 30, 1997   June 30, 1997
                                            ------------------   -------------
Current Liabilities:
Accounts payable ..............................   $  1,938,582    $  1,638,288
Short-term borrowings .........................         40,385         435,225
Current maturities of
 long-term debt ...............................          7,611         448,729
Current portion of
  obligations under
  capital leases ..............................         11,237           8,276
Due to related
  parties .....................................        262,795         296,472
Notes payable to
  officer .....................................        140,113         160,000
Accrued liabilities ...........................        223,077         257,973
                                                  ------------    ------------
   Total Current Liabilities ..................   $  2,623,800    $  3,244,963
                                                  ------------    ------------
Other Liabilities:
Long-term debt excluding current
 maturities ...................................      1,060,585       2,312,556
Long-term portion of obligations
  under capital leases ........................         34,323          27,911
                                                  ------------    ------------ 
   Total Other Liabilities ....................      1,094,908       2,340,467
                                                  ------------    ------------
Commitments and Contingencies .................         - - -           - - -
                                                  ------------    ------------
Stockholders' Equity (Impairment):
 Common stock, $.01 par value,
  25,000,000  shares  authorized, 16,936,204
  and 14,779,085 shares issued and 
  outstanding at September 30 and June 30, 1997,
  respectively ................................        169,317         147,790
Additional paid-in capital ....................     30,330,446      27,454,982
Retained earnings (deficit)...................     (29,425,128)    (27,755,925)
                                                  ------------    ------------
Total Stockholders' Equity
       (Impairment) ...........................      1,074,635        (153,153)
                                                  ------------    ------------
Total Liabilities and
  Stockholders' Equity (Impairment)                $  4,793,343    $  5,432,277
                                                   ============    ============




                                       4
<PAGE>




                      Consolidated Statement of Operations

                                                 Three Months     Three Months
                                                Ended September  Ended September
                                                      30,1997         30,1996
                                                      -------         -------
Revenues:
Sales ..........................................   $   832,241    $    309,358

Costs and Expenses:
Cost of Sales ...............................        1,057,174         241,552
Selling, general, and administrative expenses ..     1,122,893         886,043
                                                  ------------    ------------
  Total Costs and Expenses .....................     2,180,067       1,127,595
                                                  ------------    ------------
Operating (loss) ...............................    (1,347,826)   ($   818,237)
                                                  ------------    ------------
Other Income (Expenses):
Interest income ................................            49           9,682
Interest expense ...............................      (196,577)        (23,997)
Imputed Interest on Convertible Debenture ......       (96,093)         - - -
Bad Debt Expense ...............................       (28,756)          - - -
Loss on disposal of Property and Equipment .....         - - -          (1,620)
                                                  ------------    ------------
                                                      (321,377)        (15,935)
                                                  ------------    ------------
Net (Loss) .....................................   $(1,669,203)   $   (834,172)
                                                   ============   =============
(Loss) per Share ...............................   $     (0.11)   $      (0.06)
                                                  ============   ============= 
Weighted Average Number of Shares Outstanding ..     15,016,078      13,584,604
                                                   ============   =============
Dividends Paid .................................   $      --      $       --
                                                   ============   =============





                                       5
<PAGE>


                     Consolidated Statements of Cash Flows

                                                 Three Months     Three Months
                                                Ended September  Ended September
                                                    30,1997         30,1996
                                                    -------         -------

Cash Flows From Operating Activities:
Net (loss) .....................................  $ (1,669,203)     $(834,172)
Adjustments to reconcile net (loss) to
  net cash (used for) operating activities:
  Depreciation and amortization ................        84,075         89,927
   Loss on disposal of asset ...................          --            1,620
  (Increase) decrease in assets
    Restricted cash ............................      (137,500)        (1,907)
    Accounts Receivables .......................      1,373,140         42,496
    Inventory ..................................      (365,071)      (188,567)
     Other current assets ......................        57,007        (28,480)
     Other assets ..............................       (15,167)       (34,415)
   Increase (decrease) in liabilities:
     Accounts payable ..........................       300,294         54,881
     Due to related parties ....................       (33,677)       104,929
     Accrued liabilities .......................       (34,896)         2,365
   Net adjustments to reconcile net (loss)
    to net cash (used for)  operating activities     1,228,205         42,849
                                                   ------------   ------------
       Net Cash (Used for) Operating Activities    $  (440,998)   $  (791,323)
                                                   ------------   ------------
Cash Flows From Investing Activities:
   Acquisition of property and equipment .......       (12,097)       (16,973)
   Proceeds from sale of property and equipment           --            1,500
       Net Cash Provided by (Used for)
                                                    ------------   ------------
    Investing Activities .......................       (12,097)       (15,473)
                                                    ------------   ------------
Cash Flows From Financing Activities:
   Proceeds from issuance of convertible debt ..          --        2,200,000
   Repayment of convertible debt ...............      (441,296)          --
Decrease of short term borrowings ..............      (394,840)        38,017
Proceeds of equipment loans less repayments ....         7,580         (4,035)
Repayment of notes payable officer .............       (19,887)          --
Proceeds from issuance of common stock .........     1,648,908         48,750
Payment of debt issue costs ....................        (1,917)      (162,700)
Payment of offering costs and commissions ......          --          (21,279)
                                                   ------------   ------------
      Net Cash Provided by Financing Activities        798,548      2,098,753
                                                   ------------   ------------
Net Increase in Cash ...........................   $   345,453    $ 1,291,957
                                                   ============   ============
Cash and Cash Equivalent at beginning of Year ..       422,457        263,922
                                                   ------------   ------------
Cash and Cash Equivalents at End of Period .....   $   767,910    $ 1,555,879
                                                   ============   ============



                                       6
<PAGE>


                   Notes to Consolidated Financial Statements


Note 1 - Financial Statement Presentation:

In the opinion of management, the accompanying consolidated financial statements
contain all normal and  recurring  adjustments  necessary to present  fairly the
financial  position of Mark Solutions,  Inc. and Subsidiaries (the "Company") as
of September 30, 1997 and June 30, 1997 and the results of  operations  and cash
flows for the three months ended  September  30, 1997 and 1996.  

The  accounting policies  followed  by the  Company  are set  forth in the 
Notes to  Financial Statements included in the Company's Annual Report on Form 
10-K for the fiscal year ended June 30, 1997 and such notes are  incorporated 
herein by  reference.

The results of operations for the interim periods  presented are not necessarily
indicative  of the results to be expected for the full fiscal year. 

Convertible Debenture  Conversion  Discount- The conversion discount rate to 
market value of convertible debentures to common stock is recorded as interest
expense over the period from the sale of the debentures to the first conversion 
date.  

Certain reclassifications have been made to the current and prior year amounts
to conform to the current period presentation. 

Note 2 - Inventories:

  Inventories consist of the following:

                                          September  30, 1997   June  30,  1997
                                         ------------------    ---------------
  Raw materials                              $701,358               $300,888
  Finished goods                                 -0-                  35,399
                                             ---------              --------
    Total                                    $701,358               $336,287
                                             =========              ========

                                       7
<PAGE>

Note 3 - Convertible Debentures

On August 23, 1996, the Company sold $2,200,000  principle amount 7%
convertible  debentures  due  August  22,  1998.  At June 30,  1997 the  balance
remaining on this debenture was $441,296, which was all repaid on July 21, 1997.

On January 21,1997,  the Company sold $750,000 principle amount 7% convertible
debentures  due  January 20,  1999.  The  outstanding  balance of $750,000 as of
September 30, 1997 is included in long-term debt excluding current maturities on
the accompanying balance sheet. In addition,  during September 1997, the Company
issued 11,382 shares of common stock as payment of accrued interest through June
30, 1997 on the debenture.

In June 1997,  the Company sold  $1,550,000  principle  amount 7%  convertible
debentures due June 1999. The debentures are  convertible  into shares of common
stock at a conversion  price of $0.80 per share. In September  1997,  $1,250,000
was converted into 1,562,500 ahares of common stock.  In addition,  the Company
issued  33,237  shares of common  stock as payment of  accrued  interest  on the
debentures up to the date of conversion.

Note 4 - Common Stock and Additional Paid-In Capital:

During the three months ended  September 30, 1997,  the Company issued 550,000
shares of common stock as a result of the exercise of warrants,  receiving gross
proceeds of $1,456,250.



                                        8
<PAGE>



   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
                                   OPERATIONS

General
     Mark Solutions,  Inc.'s (the "Company")  results of operations,  liquidity,
and working capital position have been  historically  impacted by sporadic sales
of its principal products,  modular steel cells. This sales pattern is primarily
the  result of the  construction  industry's  unfamiliarity  with the  Company's
products and the emergence of competition.

     The  Company's   modular  steel   products   represent  an  alternative  to
traditional concrete construction methods, and penetration into the construction
market has met  resistance  typically  associated  with an  unfamiliar  product.
Accordingly,  the  Company  has  been,  and  will  continue  to be,  subject  to
significant sales fluctuations until its modular steel cell technology  receives
greater acceptance in the construction  market,  which management  believes will
occur as new  projects  are  awarded  and  completed.  In an  attempt to achieve
greater   acceptance  in  the   architectural,   engineering  and   construction
communities,  the Company's  internal  sales and  engineering  personnel and its
network of independent  sales  representatives  conduct sales  presentations and
participate in trade shows and other promotional activities.

     The Company has expanded its marketing efforts to more aggressively  pursue
domestic  and   international   joint  venture  and   design/build   development
opportunities  to obtain  projects  and  improve its  results of  operations  in
efforts  to become  profitable.  In  addition,  the  Company  is  promoting  the
incorporation  of its  modular  cell  products  to State  prison  industries  to
capitalize on its New York State  agreement.  Since January 1, 1996, the Company
has reduced  office  staff.  From January 1996 to  September  1996,  the Company
decided not to occupy factory space,  but  outsourced the  manufacturing  of its
small modular cell projects to third party  manufacturers.  The Company occupied
new factory  facilities in October 1996. The Company will continue to review its
overhead and personnel expenses based on operating results and prospects.

     The  Company  is  continually  bidding  on  and  soliciting  joint  venture
opportunities regarding construction projects. The anticipated revenues from any
major project,  would substantially  improve the Company's operating results and
cash flow,  although no assurances  can be given that any of these projects will
be awarded to the Company.

     On July 17, 1996,  the Company was awarded a contract from the State of New
York which  management  anticipates  will  generate  revenues  of  approximately
$50,000,000  over three years ending  December 31, 1999.  Through June 30, 1997,
revenues from this contract were approximately  $3,000,000.  On August 25, 1997,
the Company received an additional order of approximately  $12,000,000 under the
New York State  agreement,  which is  scheduled  to be  completed  and billed by
December 31, 1997.

     The Company  currently  had bids  pending on  approximately  $4,500,000  in
projects.  For the three months ended September 30, 1997, the Company  submitted
bids on  approximately  $12,500,000 in projects and remains under  consideration
for $3,400,000 of these projects.

                                        9
<PAGE>

     Through its  subsidiaries,  MarkCare  Medical  Systems,  Inc.  and MarkCare
Medical Systems, Ltd. (collectively "MarkCare"), the Company continues to market
its  IntraScan  II PACS  and  teleradiology  systems  and is  forming  strategic
alliances with other  companies with related medical  products.  Effective March
1996,  the Company  entered into a master  supplier  agreement with Data General
Corporation,  a large computer hardware and systems integration  provider with a
client  base of over 1,000  institutions,  pursuant to which Data  General  will
include  the  IntraScan  II PACS  and  teleradiology  software  applications  in
proposals to healthcare  institutions.  Management  anticipates that the sale of
the  IntraScan II systems will begin to generate  revenues in the calendar  year
ending December 31, 1998, although no assurances can be given in this regard. If
the  IntraScan  marketing  plan is  successful,  management  believes  that  the
revenues  from  resulting  sales will be more constant then those of the modular
steel products  presently and will reduce  fluctuations in the Company's results
of operations and financial condition.

Results of Operations

     The  substantial  majority  of the  Company's  operating  revenues  for the
reported  periods were derived from the sale of modular  cells for  correctional
institutions.  Management believes that the sale of these modular steel products
will continue to represent the substantial  majority of the Company's  operating
revenues  through June 30, 1998.  For the three months ended  September 30, 1997
sales of the modular steel products represented 78.2% of total revenues.

     Revenues for the three months ended September 30, 1997 increased  169.0% to
$832,241  from  $309,358  for the  comparable  1996  period.  This  increase  is
attributed to the progress on five of the previously awarded projects, including
$198,400 under the New York State agreement.

     Cost of sales for the three months ended September 30, 1997, which consists
primarily of materials,  labor,  supplies,  and fixed factory overhead  expense,
increased  337% to  $1,122,893  from  $241,552  for the  comparable  1996 period
reflecting the increase in sales.  Cost of sales as a percentage of revenues was
127.0% for the three  months ended  September  30, 1997 as compared to 78.1% for
the comparable  1996 period.  This increase is  attributable to cost overruns on
several previously awarded projects due to, among other things, delays caused by
the  relocation  of its  factory in fiscal  1997.  Management  expects its gross
profit margin to improve due to operating efficiencies implemented over the last
six months. For the three months ended September 30, 1997 fixed factory overhead
expenses were $61,332. For the comparable 1996 period the Company did not occupy
factory space.  Additionally,  MarkCare's product line (primarily software sales
and  support  services)  has a  significantly  lower  cost of sales.

     Selling,  general and  administrative  expenses  for the three months ended
September  30,  1997  increased  26.7%  to  $1,122,893  from  $886,043  for  the
comparable  1996.  This  increase is  primarily  attributable  to an increase in
selling  expenses  related to the MarkCare  products,  including staff expenses,
travel and promotional  activities and the  administrative  expenses  associated
with the operation of its factory facilities for the modular cells.


                                       11
<PAGE>

Liquidity and Capital Resources

     The Company's working capital  requirements  result  principally from staff
and management  overhead,  office expense and marketing  efforts.  The Company's
working capital  requirements have historically  exceed its working capital from
operations due to the sporadic sales of its products.  Accordingly,  the Company
has been dependent and,  absent  significant  improvements  in operations,  will
continue to be dependent on the infusion of new capital in the form of equity or
debt financing to meet its working capital  deficiencies,  although no assurance
can be given that such  financing  will be available.  The Company  believes its
present  available  working  capital  and  anticipated  cash  from its  existing
contracts is sufficient to meet its operating  requirements  through  August 31,
1998. The Company obtained a $400,000 revolving line of credit collateralized by
substantially all of its assets and has no outstanding borrowings at November 3,
1997. To the extent it requires additional capital, the Company will continue to
principally look to private sources.

     For the three months  ended  September  30, 1997,  the Company sold 550,000
shares of Common  Stock  pursuant  to the  exercise of  warrants  raising  gross
proceeds of $1,456,250. Since October 1, 1997, the Company sold 30,000 shares of
Common Stock  pursuant to the  exercise of warrants  raising  gross  proceeds of
$60,000.

     The Company presently has an effective  registration  statement relating to
813,425  shares of Common  Stock  issuable  upon the  exercise of  warrants  and
options, the majority of which are exercise prices ranging from $ 2.00 to $ 5.00
per  share.  The  Company  will  initially  look to the  exercise  of  presently
outstanding  warrants and options to meet working capital deficits,  however, if
sufficient  securities are not  exercised,  the Company will be required to seek
additional  private sales of its  securities,  which,  if available,  would most
likely be at  discounts to the current  trading  price of the  Company's  Common
Stock.

     The  Company's  inventory  increased to $701,358 at September 30, 1997 from
$336,287 at June 30, 1997 due to raw material purchases and component  purchases
for the increased production volume.

     Cash and cash  equivalents  increased  from  $422,457  at June 30,  1997 to
$787,910 at  September  30, 1997  primarily  due to  proceeds  from  exercise of
warrants and options.  Working  capital  increased to $962,497 at September  30,
1997 from  $923,457  at June 30,  1997  primarily  due to the warrant and option
proceeds offset by operating expenses.


                                      11
<PAGE>




                           PART II - OTHER INFORMATION



Item 6.  Exhibits and Reports on Form 8-K


(a) Exhibits

Exhibit No.              Exhibit Description

27.1                     Financial Data Schedule








                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant has duly caused this report to be signed by the undersigned thereunto
duly authorized.


Date:   November 12, 1997

                              MARK SOLUTIONS, INC.



                                                   By:/s/ Carl Coppola
                                                   -------------------
                                                   Carl Coppola- President,
                                                   Chief Executive Officer
                                                   and Chief Financial Officer










                                       12
<PAGE>


<TABLE> <S> <C>


<ARTICLE>                     5





       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              JUN-30-1997
<PERIOD-END>                                   SEP-30-1997
<CASH>                                         767,910
<SECURITIES>                                   0
<RECEIVABLES>                                  1,811,288
<ALLOWANCES>                                   5,500
<INVENTORY>                                    701,358
<CURRENT-ASSETS>                               3,586,297
<PP&E>                                         2,460,069
<DEPRECIATION>                                 2,132,303
<TOTAL-ASSETS>                                 4,793,343
<CURRENT-LIABILITIES>                          2,623,800
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       169,317
<OTHER-SE>                                     905,318
<TOTAL-LIABILITY-AND-EQUITY>                   4,793,343
<SALES>                                        832,241
<TOTAL-REVENUES>                               832,290
<CGS>                                          1,057,174
<TOTAL-COSTS>                                  2,180,067
<OTHER-EXPENSES>                               124,849
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             196,577
<INCOME-PRETAX>                                (1,669,203)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (1,669,203)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (1,669,203)
<EPS-PRIMARY>                                  (.11)
<EPS-DILUTED>                                  (.11)
        




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission